Polu joins Frazier Healthcare

Frazier Healthcare Partners said Feb. 15 that Dr. Krishna Polu has joined the Life Sciences operating professional team as an entrepreneur-in-residence with Hawkeye Therapeutics. Dr. Polu previously served as chief medical officer at Raptor Pharmaceuticals until its acquisition by Horizon Pharmaceuticals in 2016.

15 February 2017•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles